Total Payments
$93,363
2024 Payments
$1,650
Companies
7
Transactions
46
Payment Breakdown by Category
Consulting$86,725 (92.9%)
Other$4,220 (4.5%)
Research$1,100 (1.2%)
Travel$725.60 (0.8%)
Food & Beverage$556.26 (0.6%)
Education$36.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $86,725 | 27 | 92.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,220 | 3 | 4.5% |
| Unspecified | $1,100 | 2 | 1.2% |
| Travel and Lodging | $725.60 | 2 | 0.8% |
| Food and Beverage | $556.26 | 9 | 0.6% |
| Education | $36.00 | 3 | 0.0% |
Payments by Type
General
$92,263
44 transactions
Research
$1,100
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Aimmune Therapeutics, Inc. | $71,551 | 20 | $0 (2022) |
| GlaxoSmithKline, LLC. | $11,550 | 9 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $5,775 | 8 | $0 (2024) |
| ALK-Abello, Inc | $4,220 | 3 | $0 (2022) |
| CSL Behring | $141.77 | 4 | $0 (2019) |
| Novartis Pharma AG | $86.05 | 1 | $0 (2017) |
| Abbott Laboratories | $38.63 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,650 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($1,650) |
| 2023 | $4,400 | 7 | Takeda Pharmaceuticals U.S.A., Inc. ($3,025) |
| 2022 | $21,184 | 18 | Aimmune Therapeutics, Inc. ($9,676) |
| 2021 | $65,863 | 13 | AIMMUNE THERAPEUTICS, INC. ($61,875) |
| 2019 | $144.40 | 2 | CSL Behring ($105.77) |
| 2018 | $36.00 | 3 | CSL Behring ($36.00) |
| 2017 | $86.05 | 1 | Novartis Pharma AG ($86.05) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 05/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 07/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $825.00 | General |
| 03/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 03/03/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 02/10/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 02/10/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $412.50 | General |
| 02/10/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $412.50 | General |
| 01/25/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | — | Cash or cash equivalent | $550.00 | Research |
| Study: A STUDY OF PVP001, PVP002, AND PVP003 IN HEALTHY ADULTS AND PVP001 AND PVP002 IN ADULTS WITH CELIAC DISEASE | ||||||
| 11/08/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Travel and Lodging | In-kind items and services | $662.30 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Travel and Lodging | In-kind items and services | $63.30 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $56.15 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $49.55 | General |
| Category: ALLERGY | ||||||
| 10/28/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: ALLERGY | ||||||
| 10/27/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $141.71 | General |
| Category: ALLERGY | ||||||
| 10/27/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $39.70 | General |
| Category: ALLERGY | ||||||
| 10/27/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: ALLERGY | ||||||
| 08/17/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| 07/01/2022 | ALK-Abello, Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| 06/15/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| 04/06/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $4,537.50 | General |
| 03/02/2022 | Aimmune Therapeutics, Inc. | PALFORZIA (Biological) | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| Category: ALLERGY | ||||||
| 03/01/2022 | ALK-Abello, Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,970.00 | General |
| 02/24/2022 | Takeda Pharmaceuticals U.S.A., Inc. | — | — | Cash or cash equivalent | $550.00 | Research |
| Study: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TAK-101 FOR THE PREVENTION OF GLUTEN-SPECIFIC T CELL ACTIVATION IN SUBJECTS WITH CELIAC DISEASE ON A GLUTEN-FREE DIET | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TAK-101 FOR THE PREVENTION OF GLUTEN-SPECIFIC T CELL ACTIVATION IN SUBJECTS WITH CELIAC DISEASE ON A GLUTEN-FREE DIET | Takeda Pharmaceuticals U.S.A., Inc. | $550.00 | 1 |
| A STUDY OF PVP001, PVP002, AND PVP003 IN HEALTHY ADULTS AND PVP001 AND PVP002 IN ADULTS WITH CELIAC DISEASE | Takeda Pharmaceuticals U.S.A., Inc. | $550.00 | 1 |
About Dr. Daniel Adelman, M.D
Dr. Daniel Adelman, M.D is a Allergy & Immunology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922041821.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Adelman, M.D has received a total of $93,363 in payments from pharmaceutical and medical device companies, with $1,650 received in 2024. These payments were reported across 46 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($86,725).
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Internal Medicine
- Location San Francisco, CA
- Active Since 06/14/2006
- Last Updated 09/11/2025
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1922041821
Products in Payments
- PALFORZIA (Biological) $23,301
- Kcentra (Biological) $105.77
- Xolair (Biological) $86.05
- Haegarda (Biological) $36.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in San Francisco
Lulu Tsao
Allergy & Immunology — Payments: $10,381
Allergy & Immunology $10,381
Dr. Jeffrey Davidson, M.d, M.D
Allergy & Immunology — Payments: $9,015
Allergy & Immunology $9,015
Dr. Jonathan Witonsky, M.d, M.D
Allergy & Immunology — Payments: $7,779
Allergy & Immunology $7,779
Michele Pham, M.d, M.D
Allergy & Immunology — Payments: $7,767
Allergy & Immunology $7,767
Monica Tang
Allergy & Immunology — Payments: $7,663
Allergy & Immunology $7,663
Anna Lang
Allergy & Immunology — Payments: $4,226
Allergy & Immunology $4,226